BRCA1 and cancer: Since OVAR5 and 8 cell lines are considered resistant to PARPis with no reported alterations in any of the DNA repair genes including BRCA1 and 2 (Cancer Cell Line Encyclopedia (BROAD, 2019) on the cbioportal.org), we used these cell lines for the PARPi synergy study with QC.